Playing hide-and-seek with host macrophages through the use of mycobacterial cell envelope phthiocerol dimycocerosates and phenolic glycolipids

Frontiers in Cellular and Infection Microbiology

Volumn 4, Issue NOV, 2014, Pages

  Arbues, A ^a,b,c   Lugo Villarino, G ^a,b,c   Neyrolles, O ^a,b,c   Guilhot, C ^a,b,c   Astarie Dequeker, C ^a,b,c  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

immune responses; lipids; macrophages; mycobacteria; pathogens; virulence

Indexed keywords

COMPLEMENT COMPONENT C3 RECEPTOR; EARLY SECRETORY ANTIGENIC TARGET 6; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEMBRANE LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PHENOLIC GLYCOLIPID; PHTHIOCEROL DIMYCOCEROSATE; REACTIVE NITROGEN SPECIES; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRULENCE FACTOR; GLYCOLIPID; LIPID; PHENOL DERIVATIVE;

ARTICLE; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; CELL DEATH; CELL MEMBRANE FLUIDITY; EFFECTOR CELL; GENE MUTATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; MACROPHAGE; MACROPHAGE FUNCTION; MYCOBACTERIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PHAGOSOME; PHENOTYPE; PROTEIN STRUCTURE; TRANSPOSON; TUBERCULOSIS; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; IMMUNOLOGY; MICROBIOLOGY; MYCOBACTERIOSIS;

CELL MEMBRANE; GLYCOLIPIDS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; LIPIDS; MACROPHAGES; MOLECULAR STRUCTURE; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM TUBERCULOSIS; PHENOLS;

EID: 84915731732     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2014.00173     Document Type: Article

References (37)

1. Aguilo, N., Marinova, D., Martin, C., and Pardo, J. (2013). ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the question. Front Cell Infect Microbiol 3, 88.
2. Almog, R., and Mannella, C.A. (1996). Molecular packing of cord factor and its interaction with phosphatidylinositol in mixed monolayers. Biophys J 71, 3311-3319.
3. Astarie-Dequeker, C., Le Guyader, L., Malaga, W., Seaphanh, F.K., Chalut, C., Lopez, A., and Guilhot, C. (2009). Phthiocerol dimycocerosates of M. tuberculosis participate in macrophage invasion by inducing changes in the organization of plasma membrane lipids. PLoS Pathog 5, e1000289.
4. Camacho, L.R., Constant, P., Raynaud, C., Laneelle, M.A., Triccas, J.A., Gicquel, B., Daffe, M., and Guilhot, C. (2001). Analysis of the phthiocerol dimycocerosate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J Biol Chem 276, 19845-19854.
5. Camacho, L.R., Ensergueix, D., Perez, E., Gicquel, B., and Guilhot, C. (1999). Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 34, 257-267.
6. Cambier, C.J., Takaki, K.K., Larson, R.P., Hernandez, R.E., Tobin, D.M., Urdahl, K.B., Cosma, C.L., and Ramakrishnan, L. (2014). Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids. Nature 505, 218-222.
7. Constant, P., Perez, E., Malaga, W., Laneelle, M.A., Saurel, O., Daffe, M., and Guilhot, C. (2002). Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J Biol Chem 277, 38148-38158.
8. Cox, J.S., Chen, B., Mcneil, M., and Jacobs, W.R., Jr. (1999). Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 402, 79-83.
9. Dai, S., Rajaram, M.V., Curry, H.M., Leander, R., and Schlesinger, L.S. (2013). Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog 9, e1003114.
10. Elsaidi, H.R., Barreda, D.R., Cairo, C.W., and Lowary, T.L. (2013). Mycobacterial phenolic glycolipids with a simplified lipid aglycone modulate cytokine levels through Tolllike receptor 2. Chembiochem 14, 2153-2159.
11. Guenin-Mace, L., Simeone, R., and Demangel, C. (2009). Lipids of pathogenic Mycobacteria: contributions to virulence and host immune suppression. Transbound Emerg Dis 56, 255-268.
12. Hajishengallis, G., and Lambris, J.D. (2011). Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol 11, 187-200.
13. Hashimoto, K., Maeda, Y., Kimura, H., Suzuki, K., Masuda, A., Matsuoka, M., and Makino, M. (2002). Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect Immun 70, 5167-5176.
14. Ishikawa, E., Ishikawa, T., Morita, Y.S., Toyonaga, K., Yamada, H., Takeuchi, O., Kinoshita, T., Akira, S., Yoshikai, Y., and Yamasaki, S. (2009). Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J Exp Med 206, 2879-2888.
15. Kirksey, M.A., Tischler, A.D., Simeone, R., Hisert, K.B., Uplekar, S., Guilhot, C., and Mckinney, J.D. (2011). Spontaneous phthiocerol dimycocerosate-deficient variants ofMycobacterium tuberculosis are susceptible to gamma interferon-mediated immunity. Infect Immun 79, 2829-2838.
16. Laneelle, G., and Daffe, M. (1991). Mycobacterial cell wall and pathogenicity: a lipodologist's view. Res Microbiol 142, 433-437.
17. Laneelle, G., and Tocanne, J.F. (1980). Evidence for penetration in liposomes and in mitochondrial membranes of a fluorescent analogue of cord factor. Eur J Biochem 109, 177-182.
18. Lugo-Villarino, G., Verollet, C., Maridonneau-Parini, I., and Neyrolles, O. (2011). Macrophage polarization: convergence point targeted by mycobacterium tuberculosis and HIV. Front Immunol 2, 43.
19. Maeda, N., Nigou, J., Herrmann, J.L., Jackson, M., Amara, A., Lagrange, P.H., Puzo, G., Gicquel, B., and Neyrolles, O. (2003). The cell surface receptor DC-SIGN discriminates between Mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan. J Biol Chem 278, 5513-5516.
20. Mehra, V., Brennan, P.J., Rada, E., Convit, J., and Bloom, B.R. (1984). Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 308, 194-196.
21. Mishra, A.K., Driessen, N.N., Appelmelk, B.J., and Besra, G.S. (2011). Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction. FEMS Microbiol Rev 35, 1126-1157.
22. Murry, J.P., Pandey, A.K., Sassetti, C.M., and Rubin, E.J. (2009). Phthiocerol dimycocerosate transport is required for resisting interferon-gamma-independent immunity. J Infect Dis 200, 774-782.
23. Neyrolles, O., and Guilhot, C. (2011). Recent advances in deciphering the contribution of Mycobacterium tuberculosis lipids to pathogenesis. Tuberculosis (Edinb) 91, 187-195.
24. Passemar, C., Arbues, A., Malaga, W., Mercier, I., Moreau, F., Lepourry, L., Neyrolles, O., Guilhot, C., and Astarie-Dequeker, C. (2014). Multiple deletions in the polyketide synthase gene repertoire of Mycobacterium tuberculosis reveal functional overlap of cell envelope lipids in host-pathogen interactions. Cell Microbiol 16, 195-213.
25. Reed, M.B., Domenech, P., Manca, C., Su, H., Barczak, A.K., Kreiswirth, B.N., Kaplan, G., and Barry, C.E., 3rd (2004). A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431, 84-87.
26. Riviere, M., Moisand, A., Lopez, A., and Puzo, G. (2004). Highly ordered supra-molecular organization of the mycobacterial lipoarabinomannans in solution. Evidence of a relationship between supra-molecular organization and biological activity. J Mol Biol 344, 907-918.
27. Robinson, N., Kolter, T., Wolke, M., Rybniker, J., Hartmann, P., and Plum, G. (2008). Mycobacterial phenolic glycolipid inhibits phagosome maturation and subverts the pro-inflammatory cytokine response. Traffic 9, 1936-1947.
28. Rousseau, C., Winter, N., Pivert, E., Bordat, Y., Neyrolles, O., Ave, P., Huerre, M., Gicquel, B., and Jackson, M. (2004). Production of phthiocerol dimycocerosates protects Mycobacterium tuberculosis from the cidal activity of reactive nitrogen intermediates produced by macrophages and modulates the early immune response to infection. Cell Microbiol 6, 277-287.
29. Schlesinger, L.S., Hull, S.R., and Kaufman, T.M. (1994). Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. J Immunol 152, 4070-4079.
30. Schoenen, H., Bodendorfer, B., Hitchens, K., Manzanero, S., Werninghaus, K., Nimmerjahn, F., Agger, E.M., Stenger, S., Andersen, P., Ruland, J., Brown, G.D., Wells, C., and Lang, R. (2010). Cutting edge: Mincle is essential for recognition and adjuvanticity ofthe mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J Immunol 184, 2756-2760.
31. Silva, C.L., Faccioli, L.H., and Foss, N.T. (1993). Suppression of human monocyte cytokine release by phenolic glycolipid-I of Mycobacterium leprae. Int J Lepr Other Mycobact Dis 61, 107-108.
32. Sinsimer, D., Huet, G., Manca, C., Tsenova, L., Koo, M.S., Kurepina, N., Kana, B., Mathema, B., Marras, S.A., Kreiswirth, B.N., Guilhot, C., and Kaplan, G. (2008). The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect Immun 76, 3027-3036.
33. Spencer, J.S., and Brennan, P.J. (2011). The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy. Lepr Rev 82, 344-357.
34. Stadthagen, G., Jackson, M., Charles, P., Boudou, F., Barilone, N., Huerre, M., Constant, P., Liav, A., Bottova, I., Nigou, J., Brando, T., Puzo, G., Daffe, M., Benjamin, P., Coade, S., Buxton, R.S., Tascon, R.E., Rae, A., Robertson, B.D., Lowrie, D.B., Young, D.B., Gicquel, B., and Griffin, R. (2006). Comparative investigation of the pathogenicity of three Mycobacterium tuberculosis mutants defective in the synthesis of phydroxybenzoic acid derivatives. Microbes Infect 8, 2245-2253.
35. Sut, A., Sirugue, S., Sixou, S., Lakhdar-Ghazal, F., Tocanne, J.F., and Laneelle, G. (1990). Mycobacteria glycolipids as potential pathogenicity effectors: alteration of model and natural membranes. Biochemistry 29, 8498-8502.
36. Tabouret, G., Astarie-Dequeker, C., Demangel, C., Malaga, W., Constant, P., Ray, A., Honore, N., Bello, N.F., Perez, E., Daffe, M., and Guilhot, C. (2010). Mycobacterium leprae phenolglycolipid-1 expressed by engineered M. bovis BCG modulates early interaction with human phagocytes. PLoS Pathog 6, e1001159.
37. Troegeler, A., Lastrucci, C., Duval, C., Tanne, A., Cougoule, C., Maridonneau-Parini, I., Neyrolles, O., and Lugo-Villarino, G. (2014). An efficient siRNA-mediated gene silencing in primary human monocytes, dendritic cells and macrophages. Immunol Cell Biol 92, 699-708.